Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Factors Affecting Drug Response: Overview

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...

Factors Affecting Protein-Drug Binding: Drug-Related Factors

Factors Affecting Protein-Drug Binding: Drug-Related Factors

Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

One-Year Consistent Safety, Utilization, and Efficacy Assessment of Remote Electrical Neuromodulation (REN) for Migraine Treatment.

Advances in therapy·2023

Same author

Potential Impact of 2017 American College of Cardiology/American Heart Association Hypertension Guideline on Contemporary Practice: A Cross-Sectional Analysis From NCDR PINNACLE Registry.

Journal of the American Heart Association·2022

Same author

Reducing Cardiovascular Risk in the Medicare Million Hearts Risk Reduction Model: Insights From the National Cardiovascular Data Registry PINNACLE Registry.

Circulation. Cardiovascular quality and outcomes·2022

Same author

Strategies to Reduce Low-Value Cardiovascular Care: A Scientific Statement From the American Heart Association.

Circulation. Cardiovascular quality and outcomes·2022

Same author

Real-world impact of fremanezumab on migraine symptoms and resource utilization in the United States.

The journal of headache and pain·2021

Same author

The Cardiovascular Quality Improvement and Care Innovation Consortium: Inception of a Multicenter Collaborative to Improve Cardiovascular Care.

Circulation. Cardiovascular quality and outcomes·2021

Search research articles

Related Experiment Video

Updated: May 29, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Predictors of statin adherence.

Alexander Mauskop¹, William B Borden

¹Division of Cardiology, New York Presbyterian Hospital-Weill Cornell Medical Center, NY 10021, USA. alm9078@nyp.org

Current Cardiology Reports

|September 28, 2011

Summary

Patient adherence to statin therapy is crucial for reducing cardiovascular disease risks. Factors influencing adherence include patient, physician, and health system elements, requiring physician awareness for improved patient outcomes.

Area of Science:

Cardiology
Pharmacology
Health Services Research

Background:

Statin therapy is vital for cardiovascular disease (CVD) morbidity and mortality reduction.
Effective statin use depends on consistent patient medication adherence.
Understanding adherence barriers is key to optimizing CVD prevention.

Purpose of the Study:

To identify and categorize factors influencing patient adherence to statin therapy.
To highlight the interplay between patient, physician, and health system factors.
To inform healthcare providers on strategies to improve statin adherence.

Main Methods:

Literature review and synthesis of factors affecting medication adherence.
Categorization of adherence influences into patient, physician, and health system domains.

Related Experiment Videos

Last Updated: May 29, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Analysis of interactions between different influencing factors.

Main Results:

Patient factors include demographics, socioeconomic status, comorbidities, and perceived side effects.
Physician factors encompass guideline adherence, visit frequency, and patient communication.
Health system factors involve medication cost and accessibility of care.

Conclusions:

Improving statin adherence requires a multifaceted approach addressing patient, physician, and system-level barriers.
Physician awareness of these factors is essential for enhancing patient compliance.
Optimizing statin adherence can lead to better cardiovascular health outcomes.